Zimmer Biomet Holdings (ZBH) Q4 2019 Earnings Call Transcript

  • Date: 05-Feb-2020
  • Source: The Motley Fool
  • Sector:Financial Markets
  • Country:GCC
  • Who else needs to know?

Zimmer Biomet Holdings (ZBH) Q4 2019 Earnings Call Transcript

, the discussions on this call will include certain non-GAAP financial measures.. We posted solid revenue growth, slightly above our weighted average market growth rate expectations and grew earnings per share faster than revenue.. We also made further progress in executing on our short-term priorities: supply, quality remediation, new product introductions and ZB's mission and culture.. The progress has laid the foundation for further innovation and commercial execution that will drive our accelerated growth over the long term.. Our core knee business accelerated, driven by Persona, including the recently launched Revision system.. In summary, we are very pleased with the ROSA Knee launch and the overall robotics uptake.. We still have much to prove in this business, but I'm happy with the current momentum and the performance of the dental team.. Relative to our Spine & CMF business, although we did see improvement from Q3, we continued to perform below market in the quarter.. We delivered solid financial performance in the fourth quarter with accelerated revenue growth and leveraged earnings while increasing investments for long-term growth.. In Q4, our global knee business grew 4.9% with improved execution in new product launches.. S.E.T. grew 3.1%, slightly below our expectations, but we